Related Experiment Video
Updated: Aug 24, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear
Valérie Benoit1, Alain Chariot, Laurence Delacroix
1Laboratory of Medical Chemistry and Human Genetics, Center for Molecular and Cellular Therapy and Center for Research in Experimental Cancerology, University of Liege, Liege, Belgium.
Abstract:
The oncoprotein HER-2/neu is a prosurvival factor, and its overexpression has been correlated with poor prognosis in patients with breast cancer. We report that HER-2 is a new substrate for caspase-8 and that tumor necrosis factor alpha (TNF-alpha) stimulation leads to an early caspase-8-dependent HER-2 cleavage in MCF7 A/Z breast adenocarcinoma cells defective for nuclear factor kappaB (NFkappaB) activation. We show that the antiapoptotic transcription factor NFkappaB counteracts this cleavage through induction of the caspase-8 inhibitor c-FLIP. Our results also demonstrate that this HER-2 cleavage contributes to the TNF-alpha-induced apoptosis pathway because ectopic expression of an uncleavable HER-2 protects NFkappaB-defective cells against TNF-alpha-mediated cell death. Therefore, we propose an original model in which NFkappaB exerts a new antiapoptotic function by counteracting TNF-alpha-triggered cleavage of the HER-2 survival factor.
Insights
The oncoprotein HER-2/neu, a factor promoting cell survival, is cleaved by caspase-8 upon tumor necrosis factor alpha (TNF-alpha) stimulation. Nuclear factor kappaB (NFkappaB) activation inhibits this cleavage, revealing a new anti-apoptotic role for NFkappaB in breast cancer cells.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- HER-2/neu oncoprotein overexpression is linked to poor prognosis in breast cancer.
- HER-2/neu acts as a prosurvival factor, influencing cancer cell survival and proliferation.
- Tumor necrosis factor alpha (TNF-alpha) is a key cytokine involved in inflammation and apoptosis.
Purpose of the Study:
- To investigate the role of HER-2/neu in TNF-alpha-induced apoptosis.
- To identify new substrates and regulatory mechanisms of caspase-8 in breast cancer cells.
- To elucidate the interplay between HER-2/neu cleavage, NFkappaB signaling, and apoptosis.
Main Methods:
- Utilized MCF7 A/Z breast adenocarcinoma cells with defective NFkappaB activation.
- Stimulated cells with TNF-alpha to induce caspase-8 activity and HER-2 cleavage.
- Assessed HER-2 cleavage using Western blotting and analyzed the role of NFkappaB and c-FLIP.
Main Results:
- Demonstrated that HER-2/neu is a novel substrate for caspase-8.
- Showed that TNF-alpha stimulation triggers caspase-8-dependent HER-2 cleavage in NFkappaB-defective cells.
- Confirmed that NFkappaB activation counteracts HER-2 cleavage by inducing the caspase-8 inhibitor c-FLIP.
- Established that HER-2 cleavage contributes to TNF-alpha-induced apoptosis, as preventing cleavage protects cells.
Conclusions:
- Proposed a novel model where NFkappaB exerts an antiapoptotic function by inhibiting TNF-alpha-triggered HER-2 cleavage.
- Highlighted a new mechanism by which NFkappaB signaling modulates cell survival pathways in breast cancer.
- Identified HER-2 cleavage as a critical step in TNF-alpha-mediated apoptosis, offering potential therapeutic targets.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

